Pathologist’s perspectives on reporting of tumour budding in colorectal cancer

PURPOSE: Tumour budding (TB) is an important adverse prognostic factor in colon cancer, which can also guide adjuvant treatment in stage II colorectal carcinoma. The International Tumor Budding Consensus Conference (ITBCC) recommended a three-tiered scoring system to streamline the scoring of buddin...

Descripción completa

Detalles Bibliográficos
Autores principales: Roya, Paromita, Zameer, Lateef, Dey, Debdeep, Datta, Jayati, Bardia, Anand, Mishra, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816502/
https://www.ncbi.nlm.nih.gov/pubmed/35211206
http://dx.doi.org/10.3332/ecancer.2021.1337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816502/
https://www.ncbi.nlm.nih.gov/pubmed/35211206
http://dx.doi.org/10.3332/ecancer.2021.1337

Ejemplares similares